GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cidara Therapeutics Inc (FRA:20D0) » Definitions » Float Percentage Of Total Shares Outstanding

Cidara Therapeutics (FRA:20D0) Float Percentage Of Total Shares Outstanding : 96.55% (As of May. 17, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Cidara Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cidara Therapeutics's float shares is 12.52 Mil. Cidara Therapeutics's total shares outstanding is 12.97 Mil. Cidara Therapeutics's float percentage of total shares outstanding is 96.55%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cidara Therapeutics's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cidara Therapeutics's Institutional Ownership is 5.87%.

Cidara Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Cidara Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=12.52/12.97
=96.55%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cidara Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cidara Therapeutics Inc (FRA:20D0) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
CADL ALMS THRD FHTX NVCT AVIR CRVS VNDA HUMA PLX VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
CDTX:USA
Address
6310 Nancy Ridge Drive, Suite 101, San Diego, CA, USA, 92121
Website
https://www.cidara.com
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.

Cidara Therapeutics Headlines

No Headlines